Health Authorities in the U.S. and U.K. Clear Path to Start of Clinical Trial, Patients Expected to be Dosed in Q1 2020 with Commercial Scale Material Potential 3rd Therapy to treat Phenylketonuria from Leader in PKU Therapies and 2nd Gene Therapy in Company’s...
Studies to Enroll Approximately 1,200 Patients to Determine Effectiveness of Tavapadon Across the Full Spectrum of Early- and Late-Stage Parkinson’s BOSTON–(BUSINESS WIRE)– Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain...
– 50-week global study to enroll ~350 patients across broad ALS population – Alexion Announces Planned Initiation of Pivotal Phase 3 Study of ULTOMIRIS® (ravulizumab) in ALS January 14, 2020 08:30 AM Eastern Standard Time BOSTON–(BUSINESS...
SAN FRANCISCO and RESEARCH TRIANGLE PARK, N.C., Jan. 14, 2020 /PRNewswire/ — Quantum Leap Healthcare Collaborative™ and G1 Therapeutics, Inc. (Nasdaq: GTHX) announced today a collaboration to evaluate trilaciclib, an investigational therapy designed to improve...
Leading companies are using advanced study start-up application to speed clinical trials Accelerating study start-up is a top priority among leading life sciences companies. With this shift underway, an increasing number of organizations are selecting Vault Study...
Email
Text